Categories AlphaGraphs, Earnings, Health Care
Vertex Pharmaceuticals (VRTX) Earnings: 4Q22 Key Numbers
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported total revenues of $2.3 billion for the fourth quarter of 2022. This compares to $2 billion in the same period a year ago.
GAAP net income rose 6% year-over-year to $819 million, or $3.15 per share. Adjusted EPS increased 25% to $3.76.
For full-year 2023, CF product revenues are expected to be $9.55-9.70 billion.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Fastenal Company (FAST) looks poised for a mixed start to FY25
Fastenal Company (NASDAQ: FAST) will report its first-quarter results on April 11, at 6:50 am ET. The company has been investing heavily to expand its digital footprint lately, and it
LEN, KBH: A look at these homebuilders’ expectations against a choppy housing market
Homebuilders Lennar Corporation (NYSE: LEN) and KB Home (NYSE: KBH) reported their earnings results for the first quarter of 2025 at the end of last month against a challenging housing
StubHub Holdings set to enter public markets. Here’s what to expect
After a modest start to the year, the IPO market is witnessing an increase in activity led by technology and healthcare companies. StubHub Holdings, a leading online ticket marketplace for
